REN and Hypertension: Hypertension represented the most common comorbidity (45.4%) with a total of 26 patients on renin-angiotensin-aldosterone system (RAAS) inhibitors (17 ACE-i and 9 ARBs), 16 were taking β-blockers, 13 were taking statins, 9 were taking acetylsalicylic acid, and none was taking mineral-receptor antagonists.